NCT06119945View on ClinicalTrials.gov

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 9, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

DWJ1568

One tablet of DWJ1568

DRUG

DWC202215

One tablet of DWC202215

Trial Locations (1)

Unknown

RECRUITING

H Plus YANGJI Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT06119945 - Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter